Salivary gland disease in pediatric HIV patients: an update.
Oral manifestations are one of the earliest clinical indicators of HIV infection and progression in children. Prompt recognition of these signs and symptoms by dental providers can help in the diagnosis and intervention of delaying the progression of HIV disease to AIDS. Salivary gland disease is a common manifestation of HIV infection in pediatric patients, presenting either as gland enlargement and/or xerostomia. The parotid glands by far are most frequently affected, though the other major glands are commonly involved. Diseases of the salivary glands and the corresponding quantitative changes in saliva affect the homeostasis of the oral cavity and account for significant morbidity during the progression of HIV disease. This paper summarizes the research on HIV-related salivary gland disease and outlines treatment and management considerations.
Pinto
Andres
A
Department of Oral Medicine, University of Pennysylvania, Philadelphia, Penn, USA. apinto@dolphin.upenn.edu
De Rossi
Scott S
SS
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000150:complications / Q000188:drug therapy; D002648:Child; D018678:Cholinergic Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D010309:Parotitis / Q000150:complications / Q000188:drug therapy; D012466:Salivary Gland Diseases / Q000150:complications*; D014987:Xerostomia / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D018678:Cholinergic Agents